BFRG Bullfrog AI Holdings: Forward P/S Multiple

Bullfrog AI Holdings (BFRG) is accelerating drug development through AI-driven data analysis, leveraging its partnership contracts. The projected P/S metric shows a pivot driven by the optimization of biopharmaceutical supplies to increase margins and free access to algorithms for their validation. The current figure remains around 34.50, which helps investors assess the dynamics of market expectations and the risks of capital freeze.

BFRG (Bullfrog AI) Forward Price to Sales history from 05/14/2023 to 11/13/2026

Analytical breakdowns for Bullfrog AI Holdings

- market price and analyst price targets:

Price Chart Bullfrog AI|BFRG - Average Forecast Price

- company stock capitalization data:

Market Capitalization BFRG|BFRG - Full Takeover Company Value

- issuer book value statistics:

Accounting Value per Share Bullfrog AI|BFRG - Accounting Value of Company|Market Capitalization to Book Value Ratio bullfrogai.com|BFRG - Company Total Assets

- debt and liquidity details:

- net income and valuation multiples indicators:

BFRG - Company Net Income|Projected Future Earnings Bullfrog AI Holdings|BFRG - Price to Earnings Multiple|Forward P/E Multiple Bullfrog AI|BFRG - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BFRG|BFRG - Operating profit before amortization|Net earnings per share (EPS TTM) Bullfrog AI|BFRG - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months bullfrogai.com|BFRG - Expected net earnings per share growth this year|Earnings growth forecast for next year Bullfrog AI Holdings

- company sales and revenue statistics:

BFRG - Company Revenue|Projected Sales Volume Bullfrog AI|BFRG - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio BFRG

Summary company analysis:Bullfrog AI Holdings Inc BFRG

Product sample of Bullfrog AI Holdings, Inc.

Forward P/S measures the ratio of market capitalization to expected sales volume, allowing for an assessment of the premium for potential growth prior to the publication of financial reports. By analyzing the forward P/S chart for Bullfrog AI Holdings (BFRG) on GURU.Markets, an investor can see the sensitivity of quotes to expectations for the AI platform, where the bet on unique bioinformaticians at Bullfrog AI Holdings (BFRG) directly determines the multiplier's dynamics through the market's belief in a technological breakthrough.

Key competitors

Price-to-Projected Revenue Ratio Veeva VEEV|Doximity Inc (DOCS) - Market Cap to Future Revenue Ratio|HealthEquity Corp - Forward P/S Multiple|Projected Price to Revenue Waystar Corp (WAY)|CRVL (CorVel Corporation) - Forward Price-to-Revenue Multiple|priviahealth.com - Forward Price to Sales|HURN (Huron) - Forward P/S Multiple|Forward P/S Multiple Certara Inc|Forward P/S Multiple OMCL|Market Cap to Expected Sales Ratio GoodRx Gold|Schrodinger, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales PHR|Omada Health - Forward P/S Multiple|Forward Price to Sales EVH (Evolent Health Inc)|HealthStream Corp (HSTM) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Definitive Corp (DH)|Price-to-Projected Revenue Ratio Consensus Cloud Solutions|Price-to-Projected Revenue Ratio AGL|Forward P/S Multiple ABSI|So-Young International Inc - Market Cap to Projected Revenue|Forward P/S Multiple NRC (National Research Corporation)|Market Cap to Expected Sales Ratio USA Mobility (SPOK)|OPRX - Price-to-Projected Revenue Ratio|TBRG (trubridge.com) - Market Cap to Projected Revenue|SLP: Forward P/S Multiple|Projected Price to Revenue SOPHiA GENETICS SOPH|Price-to-Projected Revenue Ratio Health Catalyst, Inc|CareCloud Corp (CCLD) - Market Cap to Expected Sales Ratio|Forward P/S Multiple RSSS|Price-to-Projected Revenue Ratio DLHC (dlhcorp.com)|Forward P/S Multiple ONMD (OneMedNet)|SCNX (Scienture Holdings) - Future Price to Revenue|HCTI - Price-to-Projected Revenue Ratio|Forward Price to Sales ISPC (iSpecimen Inc.)|WORX: Forward P/S Multiple|Projected Price to Revenue msprecovery.com MSPR|ICCT (iCoreConnect, Inc.) - Forward P/S Multiple|TRxADE HEALTH Inc (MEDS) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple ORGS (Orgenesis Corp)|Price to Expected Revenue Ratio RCM|Sharecare, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales STRM|SYRA - Price-to-Projected Revenue Ratio|Apollo Medical Holdings (AMEH) - Forward Price-to-Revenue Multiple|MODN: Forward P/S Multiple|Market Cap to Future Revenue Ratio NextGen Healthcare Corp (NXGN)